WORK Medical Technology Group LTD (WOK) Key Metrics
WOK valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $4.9M
- Enterprise value
- $11.7M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.5
- Price / book
- 0.3
- EV / EBITDA
- 23.1
- Dividend yield
- —
- Beta
- 1.74
WOK key metrics, FY2020–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsWOK returns How much profit the business earns on the capital it uses.
WOK financial health Debt, liquidity and how easily interest is covered.
WOK efficiency & capital use Working capital cycle and where the cash goes.
WOK returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
WOK debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
WOK key metrics
FY2020–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Share price at fiscal year-end | $74,900.00 | $5,140,100.00 | — | — | — | — |
| Per share | ||||||
| Revenue per share | — | — | — | — | — | $52.53 |
| Earnings per share | — | — | — | — | — | $1.16 |
| Operating cash flow per share | — | — | — | — | — | $27.20 |
| Free cash flow per share | — | — | — | — | — | $9.65 |
| Cash per share | — | — | — | — | — | $0.20 |
| Book value per share | — | — | — | — | — | $4.90 |
| Tangible book value per share | — | — | — | — | — | $3.86 |
| Capex per share | — | — | — | — | — | $17.55 |
| Debt per share | — | — | — | — | — | $4.05 |
| Shares outstanding | — | — | — | — | — | 1.0M |
| Returns & profitability | ||||||
| Return on equity (ROE) | −6.8% | −30.3% | 1.1% | 8.6% | 79.8% | 23.8% |
| Return on invested capital (ROIC) | −9.7% | −15.6% | 1.7% | 9.8% | 52.6% | 62.8% |
| Return on assets (ROA) | −3.1% | −10.5% | 0.4% | 3.1% | 13.7% | 2.1% |
| Return on tangible assets | −3.3% | −9.9% | 0.4% | 3.5% | 20.1% | 2.1% |
| Free cash flow margin | 49.9% | −99.8% | 12.0% | −21.7% | −15.8% | 18.4% |
| Income quality (OCF / net income) | — | — | 19.72 | −2.61 | −1.20 | 23.37 |
| Financial health | ||||||
| Total debt | $6.4M | $13.5M | $9.1M | $6.3M | $6.6M | $4.1M |
| Cash & short-term investments | $4.1M | $6.6M | $1.6M | $731,178 | $508,708 | $200,401 |
| Net debt | $2.4M | $6.9M | $7.5M | $5.6M | $6.1M | $3.8M |
| Debt / equity | 0.35 | 1.02 | 0.92 | 0.63 | 0.66 | 0.83 |
| Debt / assets | 0.19 | 0.37 | 0.30 | 0.25 | 0.22 | 0.07 |
| Net debt / EBITDA | 6.95 | — | 3.60 | 1.18 | 0.51 | 0.81 |
| Current ratio | 1.71 | 1.03 | 1.17 | 1.17 | 0.96 | 0.81 |
| Quick ratio | 1.40 | 0.87 | 0.93 | 0.86 | 0.63 | 0.55 |
| Interest coverage | -5.0 | -6.6 | 1.3 | 5.2 | 23.3 | 23.0 |
| Working capital | $8.5M | $647,030 | $3.2M | $2.4M | −$768,621 | −$9.2M |
| Invested capital | $20.7M | $20.1M | $17.4M | $15.6M | $16.1M | $8.8M |
| Tangible asset value | $20.2M | $15.0M | $10.0M | $10.2M | $10.3M | $4.9M |
| Net current asset value | $8.5M | $647,030 | $3.2M | $2.3M | −$1.1M | −$9.9M |
| Graham number | — | — | — | — | — | $11.33 |
| Graham net-net per share | — | — | — | — | — | −$43.14 |
| Capital allocation | ||||||
| Capex / revenue | 13.5% | 80.5% | 4.3% | 10.2% | 0.1% | 33.4% |
| Capex / operating cash flow | 21.3% | — | 26.4% | — | — | 64.5% |
| Capex / depreciation | 1.45 | 6.64 | 0.36 | 0.62 | 0.01 | 5.55 |
| R&D / revenue | 4.4% | 2.6% | 2.2% | 0.9% | 0.4% | 1.5% |
| SG&A / revenue | 44.7% | 39.6% | 13.7% | 13.0% | 6.3% | 5.4% |
| Efficiency | ||||||
| Days sales outstanding | 337.3 | 265.5 | 230.5 | 117.8 | 28.6 | 4.3 |
| Days of inventory on hand | 167.0 | 164.9 | 173.9 | 127.1 | 94.2 | 113.2 |
| Days payables outstanding | 78.4 | 115.3 | 138.8 | 146.2 | 100.3 | 99.9 |
| Cash conversion cycle (days) | 426.0 | 315.1 | 265.6 | 98.8 | 22.6 | 17.7 |
| Receivables turnover | 1.08 | 1.37 | 1.58 | 3.10 | 12.75 | 84.33 |
| Payables turnover | 4.66 | 3.16 | 2.63 | 2.50 | 3.64 | 3.65 |
| Inventory turnover | 2.19 | 2.21 | 2.10 | 2.87 | 3.87 | 3.22 |
| Asset turnover | 0.28 | 0.35 | 0.49 | 0.70 | 1.06 | 0.93 |
| Average receivables | $9.1M | $8.4M | $8.6M | $6.4M | $3.6M | $622,889 |
| Average payables | $1.6M | $2.7M | $3.6M | $6.1M | $10.2M | $11.4M |
| Average inventory | $3.4M | $3.9M | $4.5M | $5.3M | $9.6M | $12.9M |
| Intangibles / total assets | 2.9% | 2.9% | 3.3% | 3.7% | 3.5% | 1.9% |
Computed from WOK's annual financial statements (latest annual report filed January 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
WOK valuation and financial ratios
WORK Medical Technology Group LTD earned a return on equity of −6.8% and a return on invested capital of −9.7% in fiscal 2025. It ended the year with $6.4 million of debt and $4.1 million in cash and short-term investments, net debt of $2.4 million.
See the WOK income statement, the WOK chart for price history, or the WOK stock overview for the latest quote and news.
WOK key metrics FAQ
What is WORK Medical Technology Group LTD's return on equity?
WORK Medical Technology Group LTD's return on equity (ROE) was −6.8% in fiscal 2025: net income of -$1.1 million on average shareholders' equity of $15.8 million.
What is WORK Medical Technology Group LTD's ROIC?
WORK Medical Technology Group LTD's return on invested capital was −9.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does WORK Medical Technology Group LTD have?
WORK Medical Technology Group LTD had total debt of $6.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.35 and $2.4 million of net debt (6.95 times EBITDA).
What is WORK Medical Technology Group LTD's current ratio?
WORK Medical Technology Group LTD's current ratio was 1.71 at the end of fiscal 2025: current assets were 1.71 times current liabilities.